Silk Road Medical, Inc

NasdaqGS:SILK 주식 보고서

시가총액: US$1.1b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Silk Road Medical 미래 성장

Future 기준 확인 1/6

Silk Road Medical (는) 각각 연간 4.1% 및 9.6% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 5.1% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 -39.3% 로 예상됩니다.

주요 정보

4.1%

수익 성장률

4.7%

EPS 성장률

Medical Equipment 수익 성장16.7%
매출 성장률9.6%
향후 자기자본 수익률-39.3%
애널리스트 커버리지

Good

마지막 업데이트18 Jun 2024

최근 미래 성장 업데이트

Silk Road Medical, Inc (NASDAQ:SILK) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

May 03
Silk Road Medical, Inc (NASDAQ:SILK) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Recent updates

Silk Road Medical, Inc (NASDAQ:SILK) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

May 03
Silk Road Medical, Inc (NASDAQ:SILK) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?

May 02
Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?

Silk Road Medical, Inc's (NASDAQ:SILK) Shares Leap 35% Yet They're Still Not Telling The Full Story

Feb 03
Silk Road Medical, Inc's (NASDAQ:SILK) Shares Leap 35% Yet They're Still Not Telling The Full Story

A Piece Of The Puzzle Missing From Silk Road Medical, Inc's (NASDAQ:SILK) 26% Share Price Climb

Dec 20
A Piece Of The Puzzle Missing From Silk Road Medical, Inc's (NASDAQ:SILK) 26% Share Price Climb

Is Silk Road Medical (NASDAQ:SILK) Weighed On By Its Debt Load?

Nov 03
Is Silk Road Medical (NASDAQ:SILK) Weighed On By Its Debt Load?

Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?

Aug 05
Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?

Shareholders Should Be Pleased With Silk Road Medical, Inc's (NASDAQ:SILK) Price

May 05
Shareholders Should Be Pleased With Silk Road Medical, Inc's (NASDAQ:SILK) Price

Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?

Apr 04
Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?

Silk Road Medical announces $100M common stock offering

Oct 17

Is Silk Road Medical (NASDAQ:SILK) Using Too Much Debt?

Sep 24
Is Silk Road Medical (NASDAQ:SILK) Using Too Much Debt?

Silk Road Medical GAAP EPS of -$0.44 beats by $0.02, revenue of $33.17M beats by $2.14M

Jul 26

Silk Road Medical: Divergence From Alternative Risk Premia Means Lack Of Upside Capture

Jul 19

Silk Road Medical falls after Citigroup downgrades to Sell from Neutral

Jul 11

Is Silk Road Medical (NASDAQ:SILK) Using Too Much Debt?

Jun 09
Is Silk Road Medical (NASDAQ:SILK) Using Too Much Debt?

Silk Road Medical - What A Road It Has Been

Apr 08

수익 및 매출 성장 예측

NasdaqGS:SILK - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/2026241-47-6-34
12/31/2025220-52-10-87
12/31/2024198-54-14-127
3/31/2024185-53-37-35N/A
12/31/2023177-56-34-32N/A
9/30/2023170-55-29-26N/A
6/30/2023163-53-27-24N/A
3/31/2023151-55-33-30N/A
12/31/2022139-55-38-33N/A
9/30/2022127-57-47-41N/A
6/30/2022114-61-50-43N/A
3/31/2022107-56-48-42N/A
12/31/2021101-50-44-39N/A
9/30/202194-52-44-42N/A
6/30/202190-48-41-40N/A
3/31/202178-48-43-42N/A
12/31/202075-47-43-42N/A
9/30/202073-39-34-33N/A
6/30/202070-37-36-35N/A
3/31/202070-38-33-33N/A
12/31/201963-52-30-30N/A
9/30/201956-60-30-30N/A
6/30/201949-61-31-30N/A
3/31/201942-56-28-26N/A
12/31/201835-38-24-22N/A
12/31/201714-19N/A-25N/A

애널리스트 미래 성장 예측

수입 대 저축률: SILK 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

수익 vs 시장: SILK 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

고성장 수익: SILK 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

수익 대 시장: SILK 의 수익(연간 9.6% ) US 시장( 8.7% 보다 빠르게 성장할 것으로 예상됩니다. 8.7% 연간).

고성장 수익: SILK 의 수익(연간 9.6% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: SILK (는) 3년 내에 수익성이 없을 것으로 예상됩니다.


성장 기업 발견